Aberrant epileptic activity is detectable at early disease stages in Alzheimer's disease (AD) patients and in AD mouse models. Here, we investigated in young ArcticAβ mice whether AD-like pathology renders neuronal networks more susceptible to the development of acquired epilepsy induced by unilateral intrahippocampal injection of kainic acid (IHK). In this temporal lobe epilepsy model, IHK induces a status epilepticus followed after two weeks by spontaneous recurrent seizures (SRS). ArcticAβ mice exhibited more severe status epilepticus and early onset of SRS. This hyperexcitable phenotype was characterized in CA1 neurons by decreased synaptic strength, increased kainic acid-induced LTP and reduced frequency of spontaneous inhibitory currents. However, no difference in neurodegeneration, neuroinflammation, axonal reorganization or adult neurogenesis was observed in ArcticAβ mice compared to wild-type littermates following IHK-induced epileptogenesis. Neuropeptide Y (NPY) expression was reduced at baseline and its IHK-induced elevation in mossy fibres and granule cells was attenuated. However, although this alteration might underlie premature seizure onset, neutralization of soluble Aβ species by intracerebroventricular Aβ-specific antibody application mitigated the hyperexcitable phenotype of ArcticAβ mice and prevented early SRS onset. Therefore, the development of seizures at early stages of AD is mediated primarily by Aβ species causing widespread changes in synaptic function.
| INTRODUCTION
Alzheimer's disease is the most prevalent age-related dementia, characterized by progressive neuronal dysfunctions. Early stages of Alzheimer's disease and other age-related dementia are associated with aberrant network activity, including a high incidence of unprovoked epileptic seizures (Amatniek et al., 2006; Hesdorffer, Hauser, Annegers, Kokmen, & Rocca, 1996; Scarmeas et al., 2009; Vossel et al., 2013 Vossel et al., , 2016 . Early neurochemical alterations render neuronal networks susceptible to seizure generation (Palop & Mucke, 2016) . Indeed, different mouse models of Alzheimer's disease exhibit neuronal hyperactivity and even interictal spikes long before the occurrence of plaques (Busche et al., 2012; Kam, Duffy, Moretto, LaFrancois, & Scharfman, 2016) . While hyperexcitability reduces seizure threshold in Alzheimer's disease transgenic mice (Born et al., 2014; Palop et al., 2007; Roberson et al., 2007; Westmark, Westmark, Beard, Hildebrandt, & Malter, 2008) , it is unknown whether it is causally related to onset of spontaneous recurrent seizures (SRS).
Alzheimer's disease and epilepsy, in particular, temporal lobe epilepsy, share major pathogenic mechanisms, including neurodegeneration, synaptic dysfunction, inflammation, and altered adult neurogenesis. In mouse models of temporal lobe epilepsy, loss of parvalbumin-, calbindin-, somatostatin-and neuropeptide Y-expressing interneurons occurs in CA1 and dentate gyrus early during epileptogenesis (Andre, Marescaux, Nehlig, & Fritschy, 2001; Bouilleret, Loup, Kiener, Marescaux, & Fritschy, 2000; Bouilleret, Schwaller, Schurmans, Celio, & Fritschy, 2000) . Similarly, different mouse models of Alzheimer's disease show reduced numbers of interneurons in these regions (Mahar et al., 2016; Ramos et al., 2006) ; and functional impairments of parvalbumin-expressing interneurons were directly related to network hypersynchrony in parietal cortex . In granule cells of the dentate gyrus, calbindin expression is disease stage-dependently reduced in mouse models and patients with Alzheimer's disease (Palop et al., 2003; Stefanits, Wesseling, & Kovacs, 2014) . Moreover, temporal lobe epilepsy is characterized by recurrent sprouting of mossy fibre collaterals (Buckmaster, 2012) and by ectopic expression of neuropeptide Y in dentate granule cells (Marksteiner, Ortler, Bellmann, & Sperk, 1990; Tonder, Kragh, Finsen, Bolwig, & Zimmer, 1994; Vezzani et al., 1999) . Transgenic Alzheimer's disease mouse models revealed a similar adaptation to a hyperexcitable network, including mossy fibre sprouting onto GABAergic basket cells and hilar interneurons . In both temporal lobe epilepsy and Alzheimer's disease, activation of innate immunity is an important pathogenic feature. For instance, in temporal lobe epilepsy, secreted cytokines render the neuronal network hyperexcitable and thereby more susceptible to seizures (Gardoni et al., 2011; Maroso et al., 2010; Viviani et al., 2003) . Likewise, amyloid β recruits microglia (Alzheimer, Stelzmann, Schnitzlein, & Murtagh, 1995; Meyer-Luehmann et al., 2008; Wang et al., 2015) and thus triggers inflammatory cytokine release, causing various sequelae associated with Alzheimer's disease (Heneka et al., 2013) . Finally, neurogenesis is altered in both temporal lobe epilepsy and Alzheimer's disease. Prolonged seizure activity transiently increases precursor cell proliferation (Jessberger, Romer, Babu, & Kempermann, 2005; Parent et al., 1997) , followed by neurogenic niche destruction and impaired hippocampal neurogenesis (Kralic, Ledergerber, & Fritschy, 2005; Ledergerber, Fritschy, & Kralic, 2006; Sierra et al., 2015) . In Alzheimer's disease, survival of newborn neurons is impaired in mice with plaque burden (Verret, Jankowsky, Xu, Borchelt, & Rampon, 2007) , while in young Alzheimer's disease transgenic, accelerated development of newborn granule cells leads to impaired dendritic maturation (Sun et al., 2009) .
It is difficult to disentangle which Alzheimer's diseaserelated pathological features directly contribute to seizure development and which are by-products of a hyperexcitable environment. Therefore, we investigated temporal lobe epilepsy-related epileptogenesis in ArcticAβ mice (Knobloch, Konietzko, Krebs, & Nitsch, 2007) , overexpressing human amyloid precursor protein transgene containing the Swedish and Arctic mutations. The Swedish mutation shifts the balance of the amyloid precursor protein cleavage towards the beta-secretase pathway, increasing the levels of carboxy-terminal fragments and ultimately β amyloid peptides. The Arctic mutation increases the aggregation tendency of Aβ without affecting the secretases. As neuronal dysfunctions associated with Aβ pathology occur prior to plaque deposits (Billings, Oddo, Green, McGaugh, & LaFerla, 2005; Busche et al., 2012; Kam et al., 2016) , it is possible to separate the two phenomena. We monitored the clinical course of epileptogenesis induced by intrahippocampal injection of kainic acid (IHK) in young adult ArcticAβ mice and wild-type littermates. IHK induces a status epilepticus followed by a seizure-free 2-week latent period preceding SRS onset (Bouilleret et al., 1999; Riban et al., 2002; Suzuki, Junier, Guilhem, Sorensen, & Onteniente, 1995) , allowing to causally determine the role of early Alzheimer's disease-related neurochemical alterations for epileptogenesis and development of temporal lobe epilepsy, as assessed by chronic intrahippocampal EEG recordings and immunohistochemical analysis. Finally, we tested the possible role of Aβ species and related fragments of the amyloid precursor protein (Benilova, Karran, & De Strooper, 2012) by inactivating them intracerebrally with a neutralizing antibody.
| Intrahippocampal kainic acid (IHK) injection
At the age of 12-to-15-weeks, mice anaesthetized by inhalation of 2.5%-3% isoflurane (Baxter) in oxygen were injected (Nanoject II, Drummond Scientific) with 70 nl kainic acid (5 mM in NaCl; Tocris biosciences) or an equivalent volume of NaCl into the right dorsal hippocampus (anteroposterior [AP] −1.8 mm, mediolateral [ML] −1.6 mm, dorsoventral [DV] −1.9 mm relative to Bregma) as described by (Bouilleret, Loup, et al., 2000) . For analgesia, mice were i.p. injected with 1 mg/kg buprenorphine (Temgesic ® , Reckitt Benckiser AG, Switzerland) prior and after surgery. For some experiments (indicated below), a protective dose of diazepam (5 mg/kg) was administered immediately after the end of IHK injection.
| Intrahippocampal retrovirus injection
Adult mice (2 months old) were anesthetized as described above. Retrovirus encoding enhanced green-fluorescent protein (eGFP; 1 μl) was bilaterally injected into the hilus of the dentate gyrus (AP −2.0 mm, ML ± 1.5 mm, DV −2.3 mm relative to Bregma) and the tissue was collected at 21 or 42 days postinjection (dpi). eGFP-encoding retrovirus was produced "in house", as described in (Deprez et al., 2016) . HEK 293T cells were transfected with three different plasmids containing the capsid (CMV-vsvg), viral proteins (CMV-gag/pol) and the transgene (CAG-eGFP) under the control of the CAG promoter (including the CMV CMS enhancer and chicken β-actin promoter).
| Antibody injection
A subset of mice was intracerebroventricularly injected with purified mouse anti-Aβ antibody (6E10, Aβ3-8, IgG1; Covance) or control immunoglobulin G (IgG; 4 mg/ml; kindly provided by Dr. Britta Engelhardt, Theodor Kocher Institute, University of Bern) for a local neutralization of soluble Aβ species (Sudduth, Greenstein, & Wilcock, 2013) . A bilateral infusion (5 μl each, 500 nl/min, 10 min wait prior to needle retraction) into the lateral ventricles (AP −1.8 mm, ML ± 2.75 mm, DV −2.5 mm relative to Bregma) was performed under general anaesthesia 3 days prior to the IHK injection. The tissue was collected at 18 dpi (IHK injection) for histological analysis.
| Electrode implantation for EEG
For EEG recordings, mice were implanted immediately after stereotactic injection of KA with a bipolar electrode into the same coordinates as the injection and a monopolar reference electrode was placed into the cerebellum of the left hemisphere. Two enamel insulated stainless steel wires were connected to a male connector and twisted to a bipolar electrode for EEG recordings (0.125 mm inner diameter, 0.15 mm outer diameter, distance between the tips = 0.4 mm; for details see Arabadzisz, Antal, Parpan, Emri, & Fritschy, 2005) , while two gold wires were inserted into the neck muscles for EMG recordings (for details see Palchykova et al., 2010) . Electrodes were connected through a board-to-board connector (M52-5050545, Harwin) and fixed to the skull by a combination of Prime&Bond (Dentsply) and Tetric EvoFlow (Ivoclar vivadent) while the entering electrode shaft was sheathed by Kwik-CastTM Silicone Elastomer (World Precision Instruments).
| EEG recordings and analysis
Mice were placed into custom-made recording cages within a Faraday cage. A custom-made vEEG system was used for continuous synchronous video and EEG recordings, consisting of a custom-made swivel, an amplifier and digitizer (AcqKnowledge MP100; Biopac Systems), infraredswitchable video cameras (Vivotek Inc., New Tapei City, Taiwan), NAS server (Synology), and a custom-made timer for synchronization (BASIC Stamp 2, Parallax Inc, Rocklin, CA, USA). EEG and EMG data were acquired at a sampling rate of 200 Hz.
Continuous video-EEG (vEEG) recordings were acquired after the injection until 18 days postinjection (dpi) or once at 21 dpi. To assess the acute response to IHK, vEEG recordings of the first 4 hours were manually analysed (open source software polyman, edf+). The sever it y of behaviour al seizures was categorized according to the Racine, Pinel and Rovner scale (Table 1) (Pinel & Rovner, 1978; Racine, 1972) . For each day, one hour was analysed during the activity phase (around 1 am) and during the resting phase (around 1 pm). For seizure quantification during the chronic phase, a threehour recording (11 am to 2 pm) was analysed. Seizures were defined as paroxysmal events lasting longer than 20 s that were separated by intervals of at least 1 s. The average frequency and duration of spontaneous recurrent seizures (SRS) was calculated for each mouse.
| Acute brain slice preparation
Three-month-old mice were anesthetized with sodium pentobarbital (Nembutal ® ; 50 mg/kg; i.p.) and decapitated. 300 μm -thick sagittal slices were cut on a vibratome (Leica VT 1200 S) in ice-cold cutting solution and then stored in ACSF at room temperature in an interface type holding chamber for at least 1 h. Cutting solution contained (in mM) NaCl 87, KCl 2.5, CaCl 2 0.5, MgCl 7, NaH 2 PO 4 1.25, NaHCO 3 25, glucose 10 and sucrose 75. ACSF contained (in mM) NaCl 120, KCl 3, CaCl 2 2.5, MgSO 4 2, NaH 2 PO 4 1, NaHCO 3 25, and glucose 20, and was bubbled with 95% O 2 , 5% CO 2 (pH 7.4).
| Field recordings
For the recording of extracellular population spikes glass microelectrodes of approx. 1.5 MΩ were filled with saline and placed near the border of CA1 stratum radiatum. Population spikes were evoked at 0.05 Hz with two pulses (50 ms apart) through a bipolar stimulating electrode positioned in CA3. A 15 min stable baseline was acquired before the application of 1 μM KA for 10 min. The amplitudes of the population spikes were measured using Clampfit 10 (Molecular Devices, LCC, Sunnyvale, California, United States). To evaluate changes induced by kainic acid (KA) application, mean baseline values (mean of all amplitudes 5 min before the application of KA, i.e. 15 consecutive responses) were compared to those elicited 30 min after the washout of KA (mean of 15 consecutive responses).
| Patch clamp recordings
For whole-cell patch clamp recordings CA3 area was cut away. CA1 hippocampal cells were visualized with an upright microscope (Axioscope Examiner.A1, Carl Zeiss; 63× water immersion objective). Whole-cell pipettes were pulled from thin wall glass capillaries (1.5 O.D. × 1.17 I.D., Harvard Apparatus, Massachusetts, USA) using a Zeitz DMZ Puller (Martinsried, Germany). Electrode resistances in the bath were 3-6 mV. Series resistance was monitored by a -5 mV step, and cells were discarded if this changed significantly (~20%). The intracellular solution consisted of (in mM) CsCl 140, HEPES 10, EGTA 10, MgATP 2, Na 3 GTP 0.3, pH 7.3, 290 mOsM. Cells were clamped at a holding potential of −70 mV to register spontaneous postsynaptic currents (sPSC). Currents were recorded with a multiclamp 700B (Molecular Devices, Pennsylvania, USA), and digitized at 10 kHz using a Digidata 1550 digitizer (Molecular Devices) and Clampex 10.0 (MolecularDevices). Traces were recorded with pClamp 10 and analysis of sPSCs frequencies and amplitudes were performed with MiniAnalysis (Synaptosoft, New Jersey, USA). KA (250 nM) was added for 5 min. For each condition (i.e. before the addition of KA and in the presence of KA) traces of one-minute duration were used for statistical analysis. The one-minute period where the effect of KA was maximal, was chosen for the statistical analysis.
| RNA isolation and quantitative realtime PCR
Adult mice were anesthetized, decapitated, brains were extracted rapidly on ice and hippocampus dissected. Whole-cell RNA from brain tissue was extracted using NucleoSpin RNA kit (Macherey-Nagel). cDNA was prepared using random hexamer primer (Thermo Scientific) and MuLV Reverse Transcriptase (Thermo Scientific). 1 μg of total RNA was amplified in CFX384 Touch ™ RealTime PCR detection system (Biorad) using the SYBRgreen PrecisionPLUS qPCR Mastermix (Primerdesign). The relative levels of each RNA sample were calculated by the 2-ΔΔCT method using Biogazelle, qbase plus software and were normalized to that of HPRT and eEF1a1 mRNA. Each CT value used for these calculations was the mean of triplicates of the same reaction. All primers were synthesized by Eurofins genomics. Sequences of all primers are listed in Table 2 .
| 5′-bromo-2′-deoxyuridine (BrdU) treatment
Three weeks prior BrdU treatment, adult female mice were housed together (five per cage) and bedding containing male mouse urine was introduced to the cages to induce Lee-Boot and Whitten cycle-synchronizing effects. At the age of two months, mice received two intraperitoneal injections of Pinel and Rovner (1978) .
90 mg/kg BrdU (Sigma-Aldrich, #B5002, dissolved in 0.9% NaCl) on two consecutive days. The tissue was collected at 1 dpi to assess cell proliferation and at 28 dpi to evaluate cell survival and cell fate.
| Tissue preparation for immunohistochemistry
Tissue was collected and prepared similar to the protocol of Notter, Panzanelli, Pfister, Mircsof, and Fritschy (2014) . In brief, mice were anesthetized (Nembutal ® ; 50 mg/kg; i.p.) and perfused intracardially with 15-20 ml ice-cold, oxygenated aCSF [containing (mM) NaCl 125, KCl 2.5, CaCl 2 3.7, MgCl 2 2, NaHCO 3 26, NaH 2 PO 4 1.25, glucose 25], pH 7.4, at a flow rate of 10-15 ml/min. The brain was extracted and divided into 3 blocks: rostral, medial and caudal part. All three parts were immediately immersion-fixed for 3 hours in ice-cold fixative [4% paraformaldehyde dissolved in 0.15 M sodium phosphate buffer], pH 7.4, then rinsed with PBS (pH = 7.4) and cryoprotected overnight in 30% sucrose in PBS at 4°C. The fixed tissue was cut into 70-μm (dendritic morphology) or 40-μm (rest) thick serial coronal sections using a sliding microtome and collected in ice-cold PBS. For storage, sections were transferred to a cryoprotectant solution (50 mM sodium phosphate buffer, pH 7.4, containing 15% glucose and 30% ethylene glycol; Sigma-Aldrich) and kept at −20°C.
| Immunohistochemistry
Sections were washed three times in Tris buffer (50 mM Tris, 150 mM NaCl, 0.05% Triton X-100, pH 7.4) for 10 min each and incubated overnight at 4 °C under continuous agitation with primary antibodies (Table 3 ) diluted in Tris buffer containing 2% normal goat serum (NGS) and 0.2% Triton X-100. Sections were rinsed three times in Tris buffer and incubated with the secondary antibody solution (2% NGS, Tris buffer) for 30 min at room temperature with secondary antibodies raised in goat. For immunofluorescence, secondary antibodies conjugated to AlexaFluor-488 (Invitrogen) were diluted to 1:1000 and those conjugated to Cy3 or Cy5 (Jackson ImmunoResearch Laboratories) to 1:500. After washing three times in PBS, sections were mounted to gelatin-coated glass slides and coverslipped using Fluorescence Mounting Medium (Dako). For immunoperoxidase staining, biotinylated secondary antibodies (Jackson ImmunoResearch Laboratories) were diluted 1:300 and after washing three times in Tris buffer, incubated with avidin-peroxidase-complex solution (Vectastain Elite kit, Vector Labs) at room temperature. After washing them again three times in Tris buffer, sections were stained by combining 3,3-diaminobenzidine (DAB; Sigma-Aldrich Inc.) in Tris buffer (pH 7.7) with hydrogen peroxide for 5-15 min. Sections were immediately transferred to icecold PBS and washed three times. Finally, sections were 
| Experimental design and quantification
All analyses were performed by an observed blinded to the genotype and/or age of the mice. Treatment (saline vs. kainic acid) was not blinded due to obvious morphological alterations induced by kainic acid.
| Visual scoring and image acquisition
For visual scoring of the neurodegenerative pattern (Nissl), 3-4 sections per mouse were examined using an Axioscop 2 microscope (Carl Zeiss) with bright-field illumination and either a 10x, 20× objective or 40× oil immersion objective. All images for display were acquired with a colour digital camera (AxioCam MRc5) and the corresponding software axiovision 4.5 (Zeiss).
| Densitometry analysis
Immunoperoxidase staining (CD68, NPY) intensity was assessed by densitometry analysis using the mcid software (MCID Elite 6.0, InterFocus Imaging Ltd., Cambridge, UK). First, images were digitized using a precision illuminator (Northern light Model B95, Imaging Research Inc., Brock University, St.Catharines, Canada) and CoolSnap cf photo-camera (Photometrics, Tuscon, AZ, USA) with a Micro-Nikkor (55 mm + 12 mm) objective (Nikon Corp.). Then, the grey values were calibrated (Kodak step tablet no. 310ST607) and the intensity was measured in the different regions of interest ( Figure 1a ).
To correct for variations in background staining, the intensity value was normalized to the intensity of the whole section and for each mouse, the intensity of a particular area was averaged over three to four equidistant coronal sections.
| Stereological analysis of macrophagelike cells
The number of F4/80+ macrophage-like cells was determined stereologically in series of randomly sampled brain sections (three to four per animal, sampling fraction 1/12) using an Axioplan 2 bright-field microscope (Carl Zeiss AG, Feldbach, Switzerland) with 20× (air, NA 0.75) objective and an integrated digital camera (MicroFIRE, Optronics AG, Goldach, Switzerland). The size of the granule cell layer and molecular layer of the dentate gyrus as well as the number of macrophage-like cells within these outlined regions ( Figure 1b ) were estimated using the mercator software (Mercator Pro rev. 7.8.2, Explora Nova, La Rochelle, France). The macrophage-like cells were counted exhaustively and together with the estimated thickness averaged per animal. 
F I G U R E 1

| Quantification of cell proliferation and survival
BrdU+ cells in the subgranular zone and granule cell layer of the dentate gyrus were counted in four to five sections per mouse in dorsal hippocampus using the Axioscop 2 (Carl Zeiss; 40× oil immersion lens, NA 1.3). Dorsal hippocampal volume was estimated using mercator software (compare above).
F I G U R E 2 Increase d response of ArcticAβ mice to IHK-induced epilepsy. (a) Schematic representation of the experimental design to
assess acquired epilepsy. Kainic acid injection and electrode implantation were performed in the right dorsal hippocampus, while EEGs were recorded and tissue was collected for histological analysis at 21 dpi. (b) Cresyl violet staining of the ipsilateral hippocampus. Neurodegeneration in CA1, CA3c, and the hilus, along with the dispersion of dentate granule cells, show a similar pattern in both IHK-injected (SO, stratum oriens; SP, stratum pyramidale; SR, stratum radiatum; SLM, stratum lacunosum moleculare; ML, molecular layer; GCL, granule cell layer; HL, hilus).
(c) F4/80+ macrophages invading the ipsilateral dentate gyrus and the dispersion of dentate granule cells. Stereological quantification of F4/80+ macrophages and measuring the layer thickness of GCL and ML revealed no differences between genotypes (n = 6/genotype; 3-4 sections; unpaired t-tests). 
| Sholl analysis
Fluorescent Z-stacks (spaced by 0.7 μm) throughout the entire thickness of the section were acquired with a confocal microscope (LSM710) using a 40× oil immersion objective (NA, 1.4) and ZEN 2012 black edition (Carl Zeis MicroImaging GmbH, Goettingen, Germany) software. Images were analysed with imagej (version 1.49o; Java 1.6.0_12 (Wayne Rusband, National Institutes of Health, USA). Sholl analysis (Sholl, 1953 ) (concentric circles spaced at 10 μm intervals, centred on the cell body) was used to analyse the complexity of the dendritic trees. First, neurons were traced using NeuronJ plugin (NIH ImageJ; Meijering et al., 2004) . Further Sholl analysis plugin (Anirvan Ghosh Laboratory, University of California, San Diego, La Jolla, CA, USA) was used to calculate the number of intersections between dendrites and concentric circles. For the number of intersections as a function of distance from the soma, area under the curve (AUC) was calculated and used for further statistical analysis. Dendritic morphometry (primary dendrite length, total dendrite length) was assessed with the NeuronJ plugin. In total, 14-36 cells from the groups of 5 to 8 mice per time-point were quantified.
| Spine density
Z-stacks for spine density morphology analysis of randomly selected eGFP-positive dendritic segments were obtained with a 40× oil immersion objective using a 2.7 digital zoom. Spines density quantification and spine type classification were performed using CellCounter (ImageJ). The length of each segment was measured and the number of spines/μm was quantified.
| Statistical analysis
Data are presented as mean ± standard error of the mean (SEM). Statistical analyses for multiple group comparison were performed by a one-way or two-way ANOVA with a Bonferroni post hoc test. An unpaired t-test, two-tailed, was used to compare two groups (prism software, graphpad version 6). For kainic acid-induced LTP a two-way repeated measure ANOVA was performed with a Sidak′s multiple comparisons test. To compare the distribution of spontaneous currents (inter-event interval and amplitude) a KolmogorovSmirnov test was used (differences were considered significant if p < 0.0001).
| RESULTS
| Acquired epilepsy and increased seizure-associated mortality in ArcticAβ mice
To determine whether an Alzheimer's disease-like predisposition prior to detectable plaque pathology renders the limbic neuronal network more vulnerable to excitotoxicity and affects the development of acquired epilepsy, 3-month-old ArcticAβ mice and wild-type littermates were injected intrahippocampally with kainic acid (IHK) (Figure 2a ). Upon recovery from anaesthesia, IHK induces a status epilepticus with occasional convulsive seizures in wild-type mice. ArcticAβ mice exhibited a much more severe reaction, with numerous convulsive seizures causing acute mortality. Nevertheless, the characteristic neurodegeneration pattern seen 21 days postinjection (dpi) in this model (Bouilleret, Loup, et al., 2000 , Bouilleret, Ridoux et al., 2000 , with loss of pyramidal cells in CA1 and CA3c and loss of hilar mossy cells in the dentate gyrus was the same in both genotypes (Figure 2b ). The severity and region-specificity of the cell loss were not different between the genotypes. IHK-induced granule cell dispersion in the dentate gyrus was also similar in ArcticAβ and wildtype littermates, as determined by measuring the thickness of the granule cell layer (GCL; t 20 = 1.13, p = 0.27) and the molecular layer (ML; t 20 = 1.4, p = 0.18; unpaired two-tailed t-test) (Figure 2c ). The number of invading macrophages, which was shown to correlate with the extent of granule cell dispersion (Zattoni et al., 2011) , did not differ between genotypes (ML: t 20 = 1.9, p = 0.07; GCL: t 20 = 0.2, p = 0.85; unpaired two-tailed t-test). In line with observations about the neurodegenerative pattern induced by IHK, microglial activation was not altered by the ArcticAβ transgene in the injected hemisphere (Figure 2d ). IHK led to the development of acquired epilepsy (onset of spontaneous recurrent seizures, SRS) in both genotypes, with mice exhibiting similar seizure frequency three weeks after the injection (t 7 = 0.04, p = 0.97; unpaired two-tailed t-test) (Figure 2e ). However, a fraction of ArcticAβ mice unexpectedly died during the latent phase, leading to a significantly different survival probability upon IHK (χ2(1) = 13.4, p = 0.0003; Mantel-Cox test) (Figure 2f) . Thus, Alzheimer's disease-like predisposition in 3-month-old ArcticAβ mice increases susceptibility towards IHK, possibly by altering the response to excitotoxicity and causing aberrant activity during early epileptogenesis, while having no effect on SRS frequency and associated histopathological alterations in surviving mutant mice.
| Increased response to excitatory stimulation in the hippocampal network
To study the causes of differential impact of IHK-induced status epilepticus on the hippocampal neuronal network of ArcticAβ mice, we recorded field population spikes in the main hippocampal output region, CA1, in tissue slices (Figure 3a) . A current-voltage plot illustrates the significantly different slope (p < 0.01, F 1,16 = 9.9) of recorded population spikes as a function of stimulus intensity in wild-type compared to ArcticAβ mice (Figure 3b) . This difference suggests that the strength of synaptic transmission in CA1 is reduced in ArcticAβ mice, which is consistent with previous findings in other AD transgenic mice .
Kainic acid (KA) has recently been shown to induce an NMDA-independent form of long-term potentiation (LTP) (Petrovic et al., 2017) . Similarly, we observed that a 10-min application of KA (1 μM) produces a stable potentiation of CA1 population spikes, which remained unchanged for at least 30 min after the drug had been washed out, in both wild-type (98.7% ± 0.9 before KA to 116.7% ± 7.4 after 30 min washout, nine slices from n = 7 different animals) and ArcticAβ mice (101.1% ± 3.36 before KA to 177.7% ± 26.10 after 30 min washout, 6 slices from n = 5 different animals) (Figure 3c ). The KA-induced potentiation was significantly higher in ArcticAβ mice compared to wild-type littermates (Figure 3d ) (two-way repeated measure ANOVA; significant effect of treatment 30 min after wash-in, F 1,10 = 8.6, p < 0.01, and genotype, F 1,10 = 8.6, p < 0.05). The latter difference was due to the F I G U R E 6 Reduced microgliosis in ArcticAβ mice during epileptogenesis. (a) Representative images of a marker for microglial activation (CD68) at 3, 6 and 14 dpi compared to control levels. Scale bar, 250 μm. (b) Densitometric analysis of CD68-IR in controls, in mice dying during SE, as well as at 1, 3, 6, and 14 dpi. Both ArcticAβ mice (n = 4-5/time-point; red stars) and wild-type littermates (n = 5-7/time-point; black stars) showed increased CD68-IR compared to baseline control over the time course of early epileptogenesis in all layers of the ipsilateral and in some layers of the contralateral hippocampus (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; two-way ANOVA, Bonferroni post hoc test). Analysis revealed a significant group difference in the SO of CA3a,b and the hilus (green stars; compare Table 5 stronger effect of KA in slices of ArcticAβ mice (Sidak′s multiple comparison post hoc test). Although not significant, we observed a tendency towards reduced paired pulse ratio after KA in ArcticAβ mice (Figure 3e) , suggesting some degree of presynaptic involvement in their enhanced response to KA.
| Impairment of the inhibitory circuit in CA1
To examine the response of the inhibitory CA1 microcircuit to KA application without interfering pharmacologically with KA receptors, we isolated the CA1 region from CA3 by cutting out the latter with a scalpel and performed whole-cell patch clamp recordings of CA1 pyramidal cells (Figure 4a) Notes. Densitometric analysis of CD68-IR was performed ispilaterally in the regions indicated at four time-points post-IHK (1, 3, 6, and 14 dpi) as well as in controls. (see Figure 6 ). Statistically significant differences among genotypes are indicated in bold. GCL, granule cell layer; HL, hilus; ML, molecular layer; SO, stratum oriens; SP, stratum pyramidale; SR, stratum radiatum; SLM, stratum lacunosum moleculare. Notes. Densitometric analysis of NPY-IR in ArticAβ mice and wild-type littermates was performed in the regions indicated at five time-points post-IHK (see Figure 7) . Statistically significant differences among genotypes are indicated in bold. GCL, granule cell layer; HL, hilusl ML, molecular layer; SO, stratum oriens; SP, stratum pyramidale; SR, stratum radiatum; SLM, stratum lacunosum moleculare.
T A B L E 5 Statistical analysis of NPY-immunoreactivity
of baseline activity, whereas the application of 20 μM bicuculline blocked most spontaneous activity (data not shown). Therefore, we will henceforth refer to the recorded spontaneous events as sIPSCs. Hippocampal network hyperactivity is an early symptom in AD (Palop & Mucke, 2016) , and an increase in inhibitory activity in the dentate gyrus of hAPP FAD mice has been postulated as a compensatory mechanism . We observed no difference in baseline frequency of sIPSCs between wild-type and ArcticAβ mice in CA1 cells, and only a small change in their amplitude. However, the application of 250 nM KA significantly diminished the frequency of events in the mutant but revealed no genotype difference in their amplitude (Figure 4b ). In slices from wild-type mice, KA increased the frequency of sIPSCs (data not shown), as shown previously (Fisher & Alger, 1984) . In line with this finding, we observed that the clustering of these events before and after KA application differed between genotypes. To quantify this phenomenon, clusters of activity were defined as groups of sIPSCs occurring within <100 ms from each other, and binned them into four main groups, containing up to three events, 4-6 events, 7-9 events or >10 events (Figure 4c ). ArcticAβ mice showed more clusters with a higher number of events during baseline, which disappeared in the presence of KA, whereas the opposite occurred for wild-type mice.
| Severe status epilepticus and early seizure onset during epileptogenesis
Having observed an increased mortality in ArcticAβ mice during early stages of epileptogenesis (Figure 2f ), we used video-EEG (vEEG) monitoring to determine whether ArcticAβ mice suffer from more severe seizures during status epilepticus and die from convulsive seizures during the latent phase (Figure 5a ). During the first four hours of status epilepticus, ArcticAβ mice had more severe behavioural seizures (stage 6-7 of the Racine-Pinel-Rovner scale; Table 1 ) than wild-type littermates even after reducing the dose of KA by half to 2.5 mM (Figure 5b ; left panel). Tonic-clonic seizures (stage 8) were only observed in ArcticAβ mice (Figure 2f ), and were lethal in some cases. However, neither the number (Figure 5c ) nor the duration (Figure 5d ) of seizures differed between genotypes. Mortality was a major confounding factor in our study, because it implied that ArcticAβ mice that survived the status epilepticus might have only mild lesions induced by KA. Therefore, we decided to administer all mice a protective dose of diazepam (5 mg/kg) immediately after the end of IHK injection ( Figure 5a ). As expected, diazepam treatment strongly reduced seizure severity (stage 2-3 of the Racine-Pinel-Rovner scale; Figure 5b ; right panel) and frequency (convulsive: F 1 = 52.94, p < 0.0001; nonconvulsive: F 1 = 6.16, p = 0.025; Figure 4c ), while having no effect on seizure duration (Figure 4d) . Moreover, diazepam treatment after IHK injection averted status epilepticus-associated mortality, but not mortality occurring during the latent phase (Figure 5f ). Thus, increased susceptibility to severe behavioural seizures can not only be evoked by a proconvulsant, but also by spontaneous aberrant network activity in a later stage of epileptogenesis.
To determine whether abnormal EEG activity during early epileptogenesis is associated with mortality during the latent phase, we acquired continuous vEEG recordings during the progress of epileptogenesis. As reported (Arabadzisz et al., 2005; Riban et al., 2002) , wild-type mice exhibit initially low voltage spikes or sharp waves (200-800 μV, 1-3 Hz), whereas SRS (800-1,500 μV, 3-5 Hz, duration >20 s) appear two weeks after IHK injection (Figure 5e ). ArcticAβ mice, however, showed a mixture of low voltage spikes and sharp waves (200-800 μV, 1-3 Hz) up to 3-4 dpi, with a subsequent early onset of SRS-like events (800-1,500 μV, 3-5 Hz, duration 10-20 s) at 4-5 dpi (Figure 5e ). These early short SRS were progressively replaced by regular SRS (duration > 20 s) from 12 dpi on. Interestingly, mortality of ArcticAβ mice during the latent phase ( Figure 4f ) was associated with early onset of SRS at 3 dpi (Figure 5e ). Thus, ArcticAβ mice are more susceptible to the development of seizures, even when they are "protected" with diazepam during the IHK-induced status epilepticus. These findings suggest that early onset of SRS in ArcticAβ mice is due either to a missing anticonvulsive protection or a premature proconvulsive environment during the otherwise seizure-free latent period.
| Gradual progression of neurodegeneration and microgliosis during epileptogenesis
Neurodegeneration and inflammation play an important role in the pathogenesis of both AD (Heppner, Ransohoff, & Becher, 2015) and TLE (Vezzani & Viviani, 2015) . To test whether the hyperexcitable phenotype observed in ArcticAβ mice accelerates the development of a pro-epileptogenic lesion, we determined the course of neurodegeneration (data not shown) and microglial activation (CD68 immunoreactivity) in the dorsal hippocampus at different time-points (1, 3, 6, 14 dpi) of epileptogenesis ( Figure 6 and Table 4 ). Cresyl violet staining in adjacent sections was used to assess the neurodegenerative pattern. As expected (Bouilleret et al., 1999) , hilar cells in the dentate gyrus were lost and pyramidal cells in CA1 became pyknotic within 24 h. During the progression of epileptogenesis, pyramidal cells in CA1 and in CA3c gradually degenerated, starting at 3 dpi up to an almost complete disappearance at 14 dpi. Dentate gyrus GC dispersion was clearly evident at 14 dpi (data not shown) and progressed further at 21 dpi (Figure 2b) . Both genotypes showed a gradual increase in CD68-IR (a marker of microglia activation) compared to control animals over a | GSCHWIND et al.
two-week period in the ipsilateral hippocampus (in all layers of CA1, the stratum lacunosum moleculare, CA3c and the strati pyramidale and radium of CA3 a,b; Figure 6 and Table 4 ). Microgliosis peaked between 1 and 6 dpi in the hilus and the stratum lucidum, while being very low in the molecular layer and GC layer. Interestingly, ArcticAβ mice exhibited a less enhanced CD68-IR compared to wild-type mice in the stratum oriens of CA3a,b at 1 dpi, and at 6 dpi in the hilus of the ipsilateral hippocampus (Table 4 ). The contralateral hemisphere showed increased CD68-IR except in stratum pyramidale of CA1, the stratum lacunosum moleculare, or CA3c (Figure 6b ).
In addition, tissue of ArcticAβ mice that died during status epilepticus (~45 min after injection; Figure 2f ) was compared to a group of wild-type littermates perfused 45 min postinjection ("SE group"). We evaluated whether these ArcticAβ mice belonged to a subgroup with particularly pronounced sequelae associated with the AD pathology (including ectopic cell death and aggravated inflammation). Cresyl violet (data not shown) and CD68-IR (Figure 6b ) revealed no difference between genotypes or between hemispheres suggesting that neither an AD-like predisposition nor the IHK injection affected cellular integrity or microglial activation during early status epilepticus. Thus, the general progression of neurodegeneration and microgliosis does not reflect increased vulnerability to aberrant excitation and does not predict early onset of SRS in AD transgenic mice during IHK-induced epileptogenesis.
| Examining the course of epileptogenesis revealed an impaired upregulation of neuropeptide Y in ArcticAβ mice
Neuropeptide Y has anticonvulsive properties and is immediately upregulated in mossy fibres after increased excitation (Gotzsche et al., 2012; Guo, Castro, Palmiter, & Baraban, 2002; Tu, Timofeeva, Jiao, & Nadler, 2005) . Reduced NPY expression has been reported in patients (Beal et al., 1986; Minthon, Edvinsson, Ekman, & Gustafson, 1990 ) and animal models of AD (Ramos et al., 2006) . Therefore, we determined whether AD-like pathology in 3-month-old ArcticAβ mice interferes with seizure-induced upregulation of NPY in the dorsal hippocampus at different time-points (1, 3, 6, 14 dpi) of epileptogenesis.
In contrast, epileptogenesis-associated increase in neuropeptide Y expression was altered in ArcticAβ mice (Figure 7 and Table 5 ). In wild-type mice, neuropeptide Y-IR was increased bilaterally, reaching significance in a region-and time-dependent manner across the various regions of the hippocampal formation (Figure 7b ). The increase was seen in both the granule cells and mossy fibres, as well as in interneurons contralaterally in CA1 and CA3. In comparison, ArcticAβ mice only displayed a moderate increase in neuropeptide Y-IR at 1-3 dpi ipsilaterally and at 1-14 dpi contralaterally in the hilus and CA3c (Figure 7 and Table 5 ). In the so-called SE group, there was no difference between wild-type mice perfused 45 min after injection and ArcticAβ mice that died due to a severe status epilepticus (Figure 7b) . Thus, while status epilepticus provokes a transient increase in NPY in dorsal hippocampus of wild-type mice, peaking after 24 hours and gradually declining over two weeks, this mechanism seems to be partially impaired in ArcticAβ mice. In line with these findings, reduced neuropeptide Y expression has been reported in patients (Beal et al., 1986; Minthon et al., 1990 ) and animal models of Alzheimer's disease (Ramos et al., 2006) .
| Impairment of NPY expression as an early sequelae of AD pathology
Interestingly, when we determined the hippocampal expression of markers involved in NPY signalling, ArcticAβ mice showed a significantly reduced expression of NPY at both three and nine months of age (F 1,16 = 4.7, p = 0.047; two-way ANOVA, Bonferroni post hoc test; Figure 8a ). The NPY receptor 1 (YR1) expression was not affected (F 1,16 = 1.12, p = 0.3064; two-way ANOVA; Figure 8b ), but ArcticAβ mice exhibited an increase in YR2 expression at nine months (F 1,16 = 1.12, p = 0.3064; two-way ANOVA; Figure 8c ) and a reduced YR5 expression at three months of age (F 1,16 = 1.12, p = 0.3064; two-way ANOVA; Figure 8d ).
Previous studies in hAPP-J20 mice reported sprouting of NPY+ axons in the molecular layer, ectopic expression of NPY in mossy fibres, increased recurrent sprouting of mossy fibre collaterals (Timm staining or zinc transporter ZnT3-IR) and depletion of calbindin (CB) in GC (Palop et al., 2003 . Increased levels of neuropeptides, most notably NPY in areas with high plaque burden, might reflect an attempt to counteract degeneration (Diez et al., 2003). Therefore, we determined whether NPY, ZnT3 and CB were changed in naive ArcticAβ mice before (three months) or after (nine months) occurrence of Aβ plaques (Figure 8e-g ). Compared to wild-type littermates (n = 6-8/ time-point) no difference in NPY-IR was observed in the hilus and molecular layer of the dentate gyrus at either time-point (Figure 8e) . Similarly, visual assessment of ZnT3-IR (Figure 8f ) and CB-IR (Figure 8g ) in GCs and in CA3 revealed no difference between genotypes. Together, these observations suggest that, albeit NPY and YR5 gene expression is reduced in ArcticAβ mice prior to occurrence of Aβ plaques, NPY-IR remains unaffected in 9-month-old mutants.
| Plaque pathology in Alzheimer's disease and associated inflammatory response
To confirm this conclusion, we verified in 3-and 9-month-old transgenic mice that the occurrence of plaques, microglial activation and expression of inflammatory markers occur as reported in the literature (Figure 9 ). While intracellular Aβ deposits have been reported in 3-month-old ArcticAβ mice (Knobloch et al., 2007) , plaques, positive for 6E10 antibody, appear between seven and nine months of age with a progressive increase thereafter ( Figure 9a) . As seen by CD68-staining, Aβ plaques are surrounded by reactive microglia, but up to the age of nine months, there is no general microglia activation (Figure 9b ,c and Table 6 ). qPCR analysis of inflammatory cytokines in hippocampal samples revealed a decreased expression of IL-10 over time in both genotypes (two-way ANOVA, F 1,16 = 11, p = 0.004; Figure 9d ) and a different expression of IL-1β between genotypes (two-way ANOVA, F 1,16 = 4.7, p = 0.047; Figure 9e ). No difference was detected in TNFα expression between wild-type and ArcticAβ mice at the age of 3 and 9 months (F 1,16 = 1.19, p = 0.291; two-way ANOVA; Figure 9f ), whereas the expression of triggering receptor expressed on myeloid cells 2 (Trem2) -a cell surface Notes. Densitometric analysis of CD68-IR in hippocampal sections from 3-and 9-month-old ArcticAβ and wild-type mice (see Figure 9b) . No significant difference was observed in any of the regions analysed (2-way ANOVA). GCL, granule cell layer; HL, hilus; ML, molecular layer; SO, stratum oriens; SP, stratum pyramidale; SR, stratum radiatum; SLM, stratum lacunosum moleculare.
F I G U R E 1 0
Increased proliferation of newborn cells and reduced spine density in ArcticAβ mice. (a) Schematic representation of the experimental design to quantify newborn neurons. Mice received BrdU injections for two consecutive days and brain tissue was collected at day 1 and 28 post-BrdU injection to evaluate cell proliferation and survival rate, respectively. (b) Quantification and representative images of BrdU immunostaining 1 and 28 days after the last BrdU treatment. BrdU+ cells were located in the inner part of the GCL. Higher density of BrdU+ cells was common in ArcticAβ mice at 1 dpi, but there were no differences at 28 dpi (*p > 0.05, unpaired t-test). Scale bar, 160 μm. (c) Schematic representation of the experimental design to assess the dendritic arborization and spine density in adult-born neurons. Brain tissue of both genotypes was collected 21 and 42 days after the intrahippocampal injection of eGFP retrovirus. Quantification of dendritic arborization was performed by Sholl analysis measuring the number of intersections between eGFP+ dendrites and virtual concentric circles centred on the cell body and spaced by 10 μm (bottom). (d) Fluorescent images of representative examples of eGFP+ cells in each genotype at 21 and 42 dpi. Quantitative result of Sholl analysis showed no significant difference, but a trend towards a reduced dendritic arborization in ArcticAβ compared to wild-type mice at 21 dpi. There were no differences between genotypes at 42 dpi. Scale bar, 50 μm. (e) Dendritic spine classification analysis. Representative images of dendritic segments from eGFP expressing GCs of wild-type and ArcticAβ mice at 21 and 42 dpi (scale bar, 5 μm). Quantification of mushroom, stubby, thin and overall spine density. ArcticAβ mice had significantly reduced overall spine density and specifically thin spine density at 21 dpi and a reduced stubby spine density at 42 dpi with no difference in the overall spine density (*p > 0.05, unpaired t-test). There were no genotype differences in the proportion of the three types of spines. Quantitative data represent mean ± SEM. [Colour figure can be viewed at wileyonlinelibrary.com] receptor expressed on microglia cells that was proposed to be important for phagocytosis and removal of apoptotic cells and β-amyloid without being accompanied by inflammation (Colonna & Wang, 2016 ) -was increased concomitant with the appearance of Aβ plaques in 9-month-old ArcticAβ mice (F 1,16 = 6.8, p = 0.02; two-way ANOVA, Bonferroni post hoc test; Figure 9g ).
| Genotype-specific differences in hippocampal adult neurogenesis
A large body of literature suggests a direct link between aberrant excitability and adult neurogenesis (Jessberger et al., 2005; Kralic et al., 2005; Ledergerber et al., 2006; Sierra et al., 2015; Song et al., 2012) . We explored the hypothesis
that ArcticAβ mice, like other AD transgenic mice (Sun et al., 2009 ), show impaired neurogenesis, which has been reported to exacerbate KA-induced status epilepticus (Iyengar et al., 2015) . To assess proliferation and survival rate of newborn cells in the subgranular zone (SGZ) of the dentate gyrus, mice were injected with BrdU and tissue was collected at 1 and 28 dpi to assess proliferation and cell survival, respectively (Figure 10a) . At 1 dpi, ArcticAβ mice showed significantly more BrdU+ cells in the SGZ compared to wild-type littermates (14039 ± 1243 cells/ mm 3 , n = 8; 10415 ± 728 cells/mm 3 , n = 8; data shown as mean ± SEM; p = 0.03, paired, two-tailed Student's t-test), while there was no difference between genotypes at 28 dpi (ArcticAβ: 2663 ± 261.8 cells/mm 3 , n = 9; wild-type:
3384 ± 491 cells/mm 3 , n = 9; data shown as mean ± SEM; p = 0.21, paired, two-tailed Student's t-test) (Figure 10b ).
To determine the fate of BrdU + cells at 28 dpi, we used neuronal (NeuN) or astroglial (GFAP) markers. In both genotypes a similar proportion of neuronal (NeuN/BrdU; wild-type: 89.4% ± 2.6%, n = 9; ArcticAβ: 91.5% ± 3.5%, n = 7) and astroglial (GFAP/BrdU; wild-type: 7.5% ± 2.5%, n = 9; ArcticAβ: 5.9% ± 3.1%, n = 7) progenitors were observed. Furthermore, we examined the morphological development of immature (21 dpi) and mature (42 dpi) newborn neurons infected with a retrovirus expressing eGFP (Figure 10c ). Sholl analysis of adult-born GC at 21 and 42 dpi revealed a tendency towards a reduced dendritic arborization between genotypes (Figure 10d ). However, further away from the soma, starting from 150μm, this difference was statistically significant at both 21 dpi (wildtype: 197.4 ± 31, n = 27; ArcticAβ at 21 dpi: 70 ± 23, n = 14; p = 0.0094) and 42 dpi (wild-type: 359 ± 25, n = 36; ArcticAβ: 258 ± 34, n = 17; p = 0.0221; data displayed as area under the curve (AUC), mean ± SEM, paired, two-tailed Student's t-test). Moreover, dendritic spine density was assessed and spines were classified in three subgroups (Figure 10e ). Overall spine density was significantly reduced in ArcticAβ mice at 21 dpi, with a specific reduction in thin spines. At 42 dpi, adult-born GC of ArcticAβ mice had significantly fewer stubby spines, while overall spine density was normalized. At both timepoints, the proportion of spine types did not differ between animals. Although ArcticAβ mice had increased cell proliferation, the survival of both neuronal and glial progenitors seems to be reduced. Together with the reduced spine density in adult-born GC, these findings point towards a slight impairment of neurogenesis in 3-month-old ArcticAβ mice.
| Epileptogenesis-associated changes in hippocampal adult neurogenesis
Neuronal stem cells divide into reactive astrocytes after IHKinduced status epilepticus, which ultimately leads to depletion of the neuronal stem cell pool and thereby, long-term impairment of adult neurogenesis (Sierra et al., 2015) . To evaluate whether the alterations in proliferation and survival of progenitor cells in ArcticAβ mice accelerates the disruption of neurogenesis during epileptogenesis, we analysed DCX + neuronal precursor cells at different time-points (1, 3, 6, 14 dpi) after IHK-induced status epilepticus (Figure 11 ). DCX-IR decreased over time in both genotypes (two-way ANOVA, F 4, 40 = 38.9, p < 0.0001), and at a similar rate (Figure 11a ), as previously described in wild-type mice (Ledergerber et al., 2006) . In controls, DCX + cells, which are located close to the SGZ, send their dendrites into the molecular layer (Figure 11a ). Ipsilaterally, DCX+ processes disappear within 1 dpi, followed by a gradual disappearance of most cell bodies until 14 dpi. Contralaterally, DCX-IR remained unchanged until 6 dpi, and increased at 14 dpi. However, there was no difference between ArcticAβ mice and wild-type littermates. Similarly, both genotypes exhibited a comparable number of ectopic cells in the hilus (two-way ANOVA, F 11, 96 = 1.20, p < 0.2964; Figure 11b ). In addition, ArcticAβ mice that died during status epilepticus did not differ from wild-type mice at 45 min postinjection with regard to DCX-IR or number of ectopic cells in the ipsilateral hilus (Figure 11b ). Taken together, the decline of neuronal progenitors after IHK-induced epileptogenesis follows a similar course in both genotypes.
| Soluble Aβ species contribute to the early onset of SRS during IHK-induced epileptogenesis
Given that 3-month-old ArcticAβ mice do not show any plaques while constitutively overexpressing Aβ (Knobloch et al., 2007) , we aimed to determine whether a clearance of soluble Aβ species and other fragments of the amyloid precursor protein might prevent the early onset of SRS in these mice. Three days prior to the IHK-induced status epilepticus, a mouse anti-Aβ antibody (6E10) or a control IgG were bilaterally injected into the lateral ventricles on the anterioposterior plane of the IHK injection side (Figure 12a ). Mice were then subjected to continuous vEEG during the next three weeks and seizure-like events were analysed. Interestingly, injection of Aβ antibody alleviated the epileptic phenotype in comparison with an IgG injection in ArcticAβ mice (Figure 12b ). While three of four IgG-injected ArcticAβ mice exhibited regular SRS from 3 to 4 dpi, as shown above (Figure 4e ), and one died from convulsive seizures at 12 dpi, the four mice treated with Aβ antibody only had a few SRS-like events and did not develop SRS during the first 14 days post-IHK. In addition, several mice injected with IgG showed tonic-clonic seizures whereas only one of the ArcticAβ mice injected with Aβ antibody had a convulsive seizure. One IgG-injected animal exhibited multiple short clusters of spikes that were considered to be SRS-like events (b1 in Figure 12b ). In contrast, one mice injected with Aβ antibody had a transient phenotype, with only two short SRSlike events at 3 dpi, while otherwise the EEG pattern was characterized by short clusters of spikes (b2 in Figure 12b ).
Noteworthy, this mouse (c3 in Figure 12c ), like the others, revealed the normal neurodegenerative pattern of the IHKmodel (Bouilleret et al., 1999) : degeneration of pyramidal cells in CA1 and CA3c, as well as of hilar cells in the dentate gyrus (Figure 12c ). In the eight mice administered with IgG or Aβ antibodies, no GC dispersion was seen, suggesting a potential interference between the two processes. Taken together, antibody-mediated neutralization of soluble Aβ species and other fragments of the amyloid precursor protein prevented the occurrence of SRS during the latent phase in 3-month-old ArcticAβ mice, suggesting that Aβ overexpression promotes epileptogenesis in these mice.
| DISCUSSION
This study was designed to determine whether neuronal hyperactivity, which is characteristic of several mouse models of familial AD, might lead to the generation of SRS. To this end, we used the IHK-model of temporal lobe epilepsy to determine whether transgenic expression of mutant APP in Arctic Aβ mice facilitates the progression of epilepsy and seizure onset. The results indicate that ArcticAβ mice exhibit increased susceptibility towards KA-induced hyperexcitability long before the stage of plaque formation. In these mice, the strength of GABAergic inhibition in the CA1 region is reduced and LTP is facilitated. Hyperexcitability in ArcticAβ mice leads to lethal convulsions during status epilepticus, which can be prevented by diazepam. In addition, it leads to the premature onset of SRS, and in some mice, to lethal convulsive seizures during the first three weeks post-IHK. This increased seizure susceptibility does not correlate with aggravated neurodegeneration, altered synaptic reorganization, immune responses or adult neurogenesis, but is paralleled by a reduced gene expression of NPY − a neuropeptide with anticonvulsant properties − and, most strikingly, reduced upregulation of NPY-IR in granule cells of the dentate gyrus. Importantly, hyperexcitability could be reversed upon neutralization of soluble Aβ species and other fragments of the amyloid precursor protein, arguing against constitutive adaptation mechanisms and in favour of a direct effect of Aβ species on synaptic, in particular GABAergic, transmission in the hippocampal formation. Therefore, our results are consistent with the hypothesis that seizures occurring in AD patients, especially at early disease stages, are due to synaptic and neuronal effects of Aβ species.
| Hyperexcitability and epileptogenesis in AD mouse models
AD is associated with network abnormalities, characterized by hypersynchrony and altered oscillatory activity that precede clinical disease onset (Palop & Mucke, 2016) . Epileptiform activity has been reported in AD patients, in particular at early stages (Amatniek et al., 2006; Scarmeas et al., 2009; Vossel et al., 2013 Vossel et al., , 2016 and with a higher incidence during sleep (Horvath, Szucs, Barcs, & Kamondi, 2017; Lam et al., 2017) . Recent studies confirmed that hyperexcitability in AD mouse models appears prior to plaque and tangle pathology. For example, 25% CA1 pyramidal cells are hyperactive in mice overexpressing human APP with a Swedish mutation and mutant human presenilin 1 (APP/PS1) already at an age of 1.5 months (Busche et al., 2012) . This neuronal dysfunction was rescued by acute treatment with a γ-secretase inhibitor and neuronal hyperexcitability was induced in wild-type mice by applying soluble Aβ. Although which cell types are most vulnerable and therefore first affected by Aβ is not fully clarified, interneurons are among the earliest cells affected. Axonal loss of SOM+ interneurons in CA1 was reported in APP/PS1 mice at preplaque stage, and at later stages correlating with proximity to Aβ plaques (Schmid et al., 2016) , suggesting that GABAergic boutons are affected early by soluble Aβ species. In line with these findings, we found in young ArcticAβ mice that decreased synaptic strength and increased KA-induced LTP are associated with changes in sIPSCs in CA1 pyramidal cells. Unlike previous studies using mice overexpressing human APP with a Swedish mutation (hAPP-J20) at plaque-bearing stage , we did not find any increase in inhibitory activity at baseline. As suggested by , increased inhibitory activity might be a compensatory response to an hyperexcitable phenotype. Such compensatory mechanism might explain clustered sIPSCs at baseline in ArcticAβ mice ( Figure 5 ). Ectopic expression of NPY and sprouting of GABAergic axons has been reported in different AD mouse models (Chin et al., 2004; Palop et al., 2007; Roberson et al., 2007) . Our results indicate that these effects differ between models, especially in the timing of their appearance. Nevertheless, plaque-independent Aβ toxicity appears as a predominant feature altering local inhibitory circuits and increasing network excitability during early stages of the AD pathogenesis. Another factor that could have played a major role to explain the hyperexcitability phenotype of Arctic Aβ mice, as well as early SRS onset, are potential differences in adult neurogenesis (Sierra et al., 2015; Sun et al., 2009 ). However, our results reveals only minor genotype-dependent changes in adult neurogenesis, which are not exacerbated upon IHK, making this hypothesis unlikely in our view. Increased susceptibility to induced seizures have been reported in different mouse models of AD (Kam et al., 2016; Palop et al., 2007; Roberson et al., 2007 Roberson et al., , 2011 Sanchez et al., 2012; Verret et al., 2012) . AD transgenic mice show age-dependent, and therefore disease stage-dependent, occurrence of SRS with hippocampal origin (Kam et al., 2016; Minkeviciene et al., 2009; Palop et al., 2007 ). In our model, it is unclear which mechanisms underlie the development of SRS. We have shown previously that the latent period can be massively curtailed in mutant mice lacking lymphocytes (RAG1-knockout), which exhibit SRS within 24 h of IHK (Deprez et al., 2016; Zattoni et al., 2011) . Our present results indicate a key role for soluble Aβ species, but the reduced overexpression of NPY in mutant mice compared to their wild-type littermates might also be an important contributing factor, along with the differential regulation of cytokines seen in our qPCR analysis.
| The role of NPY during epileptogenesis
A body of literature examined the effect of NPY on modulating excitatory transmission and its role during different stages of epileptogenesis (Baraban, 2002; El Bahh et al., 2005) . Erickson, Clegg, and Palmiter (1996) reported that NPY-deficient mice are more susceptible to seizures induced by the GABAergic antagonist pentylenetetrazole (PTZ). Moreover, status epilepticus induced by repeated intraperitoneal injection of low dose kainic acid led to convulsive seizures in both genotypes at a similar concentration and within the same latency, but being lethal for 90% NPY-deficient mice compared to 22% wild-type littermates (Baraban, Hollopeter, Erickson, Schwartzkroin, & Palmiter, 1997) . Similarly, Y5R-deficient mice are more susceptible to KA, having more severe seizures and increased mortality (Marsh, Baraban, Hollopeter, & Palmiter, 1999) . Here, we found a similar phenotype after IHK in young ArcticAβ mice accompanied by weaker expression of NPY and Y5R at the age of injection (Figure 6 ). In contrast, NPY application (Baraban et al., 1997; Vezzani et al., 1999; Woldbye, Madsen, Larsen, Mikkelsen, & Bolwig, 1996; Woldbye et al., 1997) or hippocampal overexpression of NPY and Y2R or Y5R using rAAV vectors (Gotzsche et al., 2012; Richichi et al., 2004; Sorensen et al., 2009; Woldbye et al., 2010) were shown to have an alleviating effect on electrically or chemically induced acute seizures. In particular, seizures of higher severity and seizure-associated death were reduced upon activation of NPY signalling, while mild seizures remained unchanged. We likewise found no difference in the latency, number or duration of nonconvulsive seizures in ArcticAβ mice during IHK-induced status epilepticus (Figure 4) . Moreover, at nine months of age, hippocampal Y2R expression is increased in ArcticAβ mice, similar to plaque-bearing hAPP-J20 mice , suggesting a compensatory mechanism after months of increased excitability.
Although the similarities between NPY-deficient animals and ArcticAβ mice are compelling, additional experiments are needed to evaluate if the decrease in NPY expression is directly responsible for the hyperexcitable phenotype of the AD model. To this end, it would be interesting to test whether neutralization of soluble Aβ species (e.g., with the 6E10 antibody) would restore NPY expression and signalling in ArcticAβ mice, and thereby ameliorate the excitability in vivo and in slices.
| The role of inflammation during epileptogenesis
Perhaps the least expected finding of this study is that inflammation that accompanies neurodegeneration in the dorsal hippocampus after IHK was not more severe in ArticAβ mice, despite ongoing stimulation of innate immunity by increased Aβ species and their accumulation in the brain (Knobloch et al., 2007) . In our previous work in RAG1-KO mice (Zattoni et al., 2011) , we showed that in the absence of adaptive immunity by T and B lymphocytes, IHK causes a stimulation of innate immunity mediated by neutrophils, leading to extensive neurodegeneration in CA1-CA3 and eventually complete atrophy of the injected hippocampus. We also observed that this phenotype is accompanied by a dramatic shortening of the seizure-free latent phase that follows IHK, with RAG1-KO mice exhibiting SRS at 1-2 dpi (Zattoni et al., 2011) . Therefore, the disrupted balance between adaptive and innate immunity induces a condition in the brain of IHK-treated mice that favours SRS onset, presumably mediated by inflammation-related secreted or blood-born factors. Our present results show that the AD-like predisposition in ArticAβ mice also induces a condition that favours the occurrence of SRS during the latent phase, which is due, at least in large part to Aβ overexpression in the brain, and which does not stimulate further inflammatory mechanisms that would aggravate neurodegeneration. Both studies relativize the importance of neuronal circuit reorganization that takes place during the latent phase for SRS onset. Rather, they favour the view that the latent phase is seizure-free because of unknown protective mechanisms preventing seizure onset. These mechanisms can be overruled by immune factors or by hyperexcitability.
Therefore, despite the fact that temporal lobe epilepsy and AD share common pathogenic mechanisms and exhibit comparable alterations in inhibitory neuronal networks in the hippocampal formation, as outlined in the Introduction, there appears to be little cross-over between the two disease conditions. In AD patients, like in Artic Aβ mice subject to IHK, epileptogenic activity and unprovoked seizures are most likely related to toxic Aβ species affecting synaptic transmission and favouring a state of chronic hyperexcitability. Unravelling the exact mechanisms by which these Aβ species affect synaptic GABAergic transmission in AD and in Artic Aβ mice, and in particular, whether this alterations involves NPY signalling, will contribute to better understand the prevalence of epileptic seizures in AD.
